Japan Tissue Engineering Co (TSE:7774) Change In Receivables : 円0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co Change In Receivables?

Japan Tissue Engineering Co's change in receivables for the quarter that ended in Sep. 2024 was 円0 Mil. It means Japan Tissue Engineering Co's Accounts Receivable stayed the same from Mar. 2024 to Sep. 2024 .

Japan Tissue Engineering Co's change in receivables for the fiscal year that ended in Mar. 2024 was 円-32 Mil. It means Japan Tissue Engineering Co's Accounts Receivable increased by 円32 Mil from Mar. 2023 to Mar. 2024 .

Japan Tissue Engineering Co's Accounts Receivable for the quarter that ended in Sep. 2024 was 円485 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Japan Tissue Engineering Co's liquidation value for the three months ended in Sep. 2024 was 円3,863 Mil.

Japan Tissue Engineering Co Change In Receivables Historical Data

The historical data trend for Japan Tissue Engineering Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Tissue Engineering Co Change In Receivables Chart

Japan Tissue Engineering Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

52.21

-140.85

325.95

-79.74

-32.43

Japan Tissue Engineering Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Japan Tissue Engineering Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Japan Tissue Engineering Co (TSE:7774) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Japan Tissue Engineering Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	485.346	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Japan Tissue Engineering Co's accounts receivable are only considered to be worth 75% of book value:

Japan Tissue Engineering Co's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4036.755	-	632.183	+	0.75 * 485.346	+	0.5 * 188.289
=	3,863

Japan Tissue Engineering Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Japan Tissue Engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022

Website

https://www.jpte.co.jp

Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines